CRSP CRISPR Therapeutics

Watchlist

Close Jun 14 16:00 ET

Post 19:55 ET

5.40BMarket Cap-23540P/E (TTM)

CRISPR Therapeutics Key Stats

Currency: USD

Period

Q1 FY2024 Earnings

Revenue(YoY)

504.00K

-99.50%

EPS(YoY)

-1.43

-113.43%

Analyst Rating

Buy

May 31, 2024

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q3	-- / 17.894M	--
--	2024/Q2	-- / 14.238M	--
--	2024/Q1	504.000K / 26.883M	--
--	2023/Q4	201.206M / 123.085M	--
--	2023/Q3	0.000 / 7.956M	--
--	2023/Q2	70.000M / 1.620M	--
--	2023/Q1	100.000M / 24.329M	--
--	2022/Q4	6.000K / 7.365M	--
--	2022/Q3	94.000K / 536.540K	--
--	2022/Q2	158.000K / 2.198M	--